You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ULTRAVIST 150 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ultravist 150 patents expire, and what generic alternatives are available?

Ultravist 150 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ULTRAVIST 150 is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ULTRAVIST 150?
  • What are the global sales for ULTRAVIST 150?
  • What is Average Wholesale Price for ULTRAVIST 150?
Drug patent expirations by year for ULTRAVIST 150
Recent Clinical Trials for ULTRAVIST 150

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Guerbet/Liebel-FlarsheimPhase 4
Duke Clinical Research InstitutePhase 4
GE HealthcarePhase 4

See all ULTRAVIST 150 clinical trials

Pharmacology for ULTRAVIST 150

US Patents and Regulatory Information for ULTRAVIST 150

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220-004 May 10, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ULTRAVIST 150

See the table below for patents covering ULTRAVIST 150 around the world.

Country Patent Number Title Estimated Expiration
Spain 489337 ⤷  Sign Up
Spain 8107165 ⤷  Sign Up
Portugal 70915 ⤷  Sign Up
Ireland 800467 ⤷  Sign Up
Japan S55153755 TRIIODOISOPHTHALIC ACID DIAMIDE DERIVATIVE* ITS MANUFACTURE AND X RAY CONTRAST AGENT CONTAINING IT ⤷  Sign Up
Norway 148884 ⤷  Sign Up
Egypt 14530 NON-IONIC X-RAY CONTRAST AGENTS ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.